Director/PDMR Shareholding

RNS Number : 2443Q

Circassia Pharmaceuticals Plc

04 June 2018

 

Persons Discharging Managerial Responsibilities / persons closely associated with them (PDMR) Notification

4 June 2018: Circassia Pharmaceuticals plc (LSE: CIR).

1 - Details of the person discharging managerial responsibilities/person closely associated

Name	Rod Hafner

2 - Reason for the notification

Position/status	Director and Senior Vice President Research & Development (PDMR)
Initial notification/amendment*	Initial Notification
In case of amendment, please enter the previous notification reference number and explain the error that this notification needs amending	N/A

3 - Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Full name of entity*	Circassia Pharmaceuticals plc
Legal Entity Identifier code	2138006YAT138TOGA556
	In accordance with ISO 1744 LEI code

4 - Details of the transaction(s)

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

Date	Description of Financial Transaction	Aggregated Price	Aggregated Volume	Total Aggregated Price
31-May-18	Grant of options under the 2018 Share Option scheme.	£0.0008	250,000	£200

i.          Award of options

Description of the financial instrument, type of instrument	Circassia Pharmaceuticals Plc 2018 Performance Share Plan
Identification Code	N/A
Nature of the transaction	Award of options
Currency	GBP
Price(s) and Volume (s)	Price Volume Total £0.0008p 250,000 £200
Aggregated Information	Price Volume Total £0.0008p 250,000 £200
Date of Transaction	31 May 2018
Place of Transaction	London: XLON

For further information, please contact:
Circassia Pharmaceuticals plc Julien Cotta, Company Secretary	[phone]

 

END

 

 

DSHBUGDLSBGBGIS